Table 1 The clinicopathological characteristics of patients
Before Matching | After Matching | ||||||
|---|---|---|---|---|---|---|---|
Type B Group (n = 840,%) | Type C Group (n = 468, %) | P | Type B Group (n = 688,%) | Type C Group (n = 445, %) | P | ||
Age, years | 46.61 ± 9.419 | 47.65 ± 9.844 | 0.059 | 46.56 ± 8.891 | 46.99 ± 9.084 | 0.436 | |
Tumor Diameter, cm | 0.911 | 0.819 | |||||
2.1 ∼ 3.0 | 550(65.5) | 305(65.2) | 456(66.3) | 292(65.6) | |||
3.1 ∼ 4.0 | 290(34.5) | 163(34.8) | 232(33.7) | 153(34.4) | |||
x ± s (rang) | 3.1 ± 0.5 (2.1 ∼ 4.0) | 3.2 ± 0.6 (2.1 ∼ 4.0) | 0.074 | 3.1 ± 0.6 (2.1 ∼ 4.0) | 3.2 ± 0.5 (2.1 ∼ 4.0) | 0.069 | |
Histologic type | 0.190 | 0.460 | |||||
Squamous cell | 758(90.2) | 407(87.0) | 615(89.4) | 387(87.0) | |||
Adenocarcinoma | 72(8.6) | 54(11.5) | 64(9.3) | 51(11.5) | |||
Adenosquamous | 10(1.2) | 7(1.5) | 9(1.3) | 7(1.5) | |||
Parametrial involvement | 0.233 | 0.408 | |||||
Negative | 832(99.0) | 460(98.3) | 681(99.0) | 438(98.4) | |||
Positive | 8(1.0) | 8(1.7) | 7(1.0) | 7(1.6) | |||
Vaginal margin | 0.579 | 0.178 | |||||
Negative | 832(99.0) | 462(98.7) | 684(99.4) | 439(98.7) | |||
Positive | 8(1.0) | 6(1.3) | 4(0.6) | 6(1.3) | |||
LVSI | <0.001 | 0.376 | |||||
Negative | 632(75.2) | 391(83.5) | 561(81.5) | 372(83.6) | |||
Positive | 208(24.8) | 77(16.5) | 127(18.5) | 73(16.4) | |||
Depth of stromal invasion | 0.169 | 0.583 | |||||
≤ 1/2 | 423(50.4) | 259(55.3) | 337(49.0) | 235(52.8) | |||
>1/2 | 417(49.6) | 209(44.7) | 351(51.0) | 210(47.2) | |||
Pelvic lymph nodes removed | 26.2 ± 5.0 (21 ∼ 81) | 26.6 ± 6.5 (21 ∼ 76) | 0.174 | 26.1 ± 5.1 (21 ∼ 81) | 26.5 ± 6.2 (21 ∼ 76) | 0.334 | |
Para-aortic lymph nodes removed | 0.348 | 0.289 | |||||
No | 713(84.9) | 388(82.9) | 591(85.9) | 372(83.6) | |||
Yes | 127(15.1) | 80(17.1) | 97(14.1) | 73(16.4) | |||
Standard postoperative therapy | <0.001 | 0.466 | |||||
No adjuvant required | 633(75.4) | 397(84.8) | 570(82.8) | 376(84.5) | |||
Standard adjuvant therapy | 207(24.6) | 71(15.2) | 118(17.2) | 69(15.5) | |||